Jackson Garrett R, Jawanda Harkirat, Batra Anjay, Familiari Filippo, Khan Zeeshan A, Brusalis Christopher M, Verma Nikhil N
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois, U.S.A.
Midwest Orthopaedics at Rush, Chicago, Illinois, U.S.A.
Arthrosc Sports Med Rehabil. 2023 Jul 29;5(5):100761. doi: 10.1016/j.asmr.2023.100761. eCollection 2023 Oct.
To review the Kerlan-Jobe Orthopaedic Clinic (KJOC) scores, return-to-play rates, and complications after ulnar collateral ligament (UCL) repair with suture augmentation.
A literature search of the PubMed and Scopus databases was conducted on February 17, 2023, using the terms "ulnar collateral ligament," "repair," "internal brace," and "suture augmentation." The search strategy was based on the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) protocol and included 4 articles published from 2019 to 2022. The inclusion criteria included studies reporting outcomes, return-to-play rates, and/or complications after UCL repair with suture augmentation. The exclusion criteria consisted of non-English language studies, case reports, cadaveric studies, animal studies, letters to the editor, studies with overlapping cohorts, and review articles. The risk of bias was evaluated using the Methodological Index for Non-Randomized Studies (MINORS) criteria.
The final analysis included 4 studies with 510 patients (457 male and 53 female patients), ranging in age between 17.8 and 27.5 years, treated with repair and suture augmentation for UCL tears. In this review, we found a mean postoperative KJOC score ranging from 87.9 to 92.6. The overall rate of return to play at the preinjury level or at a higher level than the preinjury level ranged from 67% to 93%; the mean time to return to play ranged from 6.7 to 17.6 months. The postoperative complication rate in this review ranged from 0% to 11.9%. Among the complications, the most common were ulnar nerve paresthesia (range, 0%-8.2%) and postoperative medial elbow pain (range, 0%-3.1%). Overall, the reoperation rate ranged from 0% to 3.4%. No reruptures were reported.
UCL repair with the use of suture augmentation results in postoperative KJOC scores ranging from 87.9 to 92.6, a return-to-play rate between 67% and 93%, and a postoperative complication rate up to 11.9%.
Level IV, systematic review of Level IV studies.
回顾采用缝线增强技术修复尺侧副韧带(UCL)后的Kerlan-Jobe骨科诊所(KJOC)评分、重返运动率及并发症情况。
于2023年2月17日在PubMed和Scopus数据库进行文献检索,检索词为“尺侧副韧带”“修复”“内支架”和“缝线增强”。检索策略基于系统评价和Meta分析的首选报告项目(PRISMA)方案,纳入了2019年至2022年发表的4篇文章。纳入标准包括报告采用缝线增强技术修复UCL后的结果、重返运动率和/或并发症的研究。排除标准包括非英语语言研究、病例报告、尸体研究、动物研究、给编辑的信、队列重叠的研究和综述文章。使用非随机研究方法学指数(MINORS)标准评估偏倚风险。
最终分析纳入4项研究,共510例患者(男性457例,女性53例),年龄在17.8至27.5岁之间,接受了UCL撕裂的修复和缝线增强治疗。在本综述中,我们发现术后KJOC评分平均在87.9至92.6之间。恢复到伤前水平或高于伤前水平的总体重返运动率在67%至93%之间;平均重返运动时间在6.7至17.6个月之间。本综述中的术后并发症发生率在0%至11.9%之间。并发症中,最常见的是尺神经感觉异常(范围为0%至8.2%)和术后内侧肘部疼痛(范围为0%至3.1%)。总体而言,再次手术率在0%至3.4%之间。未报告再断裂情况。
采用缝线增强技术修复UCL术后KJOC评分在87.9至92.6之间,重返运动率在67%至93%之间,术后并发症发生率高达11.9%。
IV级,IV级研究的系统评价。